<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02138552</url>
  </required_header>
  <id_info>
    <org_study_id>2013-002708-14</org_study_id>
    <nct_id>NCT02138552</nct_id>
  </id_info>
  <brief_title>Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo</brief_title>
  <acronym>OML0113</acronym>
  <official_title>Phase II Study to Assess Bacterial Count Reduction of Three Octenidine Mouthwash Concentrations in Comparison to a Placebo in Patients With Mild Gingivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schülke &amp; Mayr GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Schülke &amp; Mayr GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical trial is to identify the most efficacious octenidine
      dihydrochloride concentration regarding bacterial count reduction in comparison to a placebo
      in the oral cavity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bacterial count reduction in saliva after a single application of OML in comparison to placebo application</measure>
    <time_frame>After 1 minute of rinsing</time_frame>
    <description>Bacterial count reduction is measured at V1 (Verum/Placebo) and V3 (Placebo/Verum) in a blinded cross-over design</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean plaque index (PI)</measure>
    <time_frame>After 5 days of application</time_frame>
    <description>PI is measured at V2 (Verum/Placebo) and V4 (Placebo/Verum) in a blinded cross-over design</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean gingival index (GI)</measure>
    <time_frame>After 5 days of application</time_frame>
    <description>GI is measured at V1/V2 (Verum/Placebo) and V3/V4 (Placebo/Verum) in a blinded cross-over design</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of taste and flavour (questionnaire)</measure>
    <time_frame>After 5 days of application</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AEs and SAEs</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>OCT 0.1% vs. Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.1 % Octenidine dihydrochloride vs. Placebo (0.9 % sodium chloride solution)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OCT 0.15% vs. Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.15 % Octenidine dihydrochloride vs. Placebo (0.9 % sodium chloride solution)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OCT 2.0% vs. Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 % Octenidine dihydrochloride vs. Placebo (0.9 % sodium chloride solution)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Octenidine dihydrochloride</intervention_name>
    <description>Mouthrinsing - comparison of different dosages of Octenidine dihydrochloride over 4 days vs. Placebo</description>
    <arm_group_label>OCT 0.1% vs. Placebo</arm_group_label>
    <arm_group_label>OCT 0.15% vs. Placebo</arm_group_label>
    <arm_group_label>OCT 2.0% vs. Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Mouthrinsing - comparison of different dosages of Octenidine dihydrochloride over 4 days vs. Placebo</description>
    <arm_group_label>OCT 0.1% vs. Placebo</arm_group_label>
    <arm_group_label>OCT 0.15% vs. Placebo</arm_group_label>
    <arm_group_label>OCT 2.0% vs. Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with mild gingivitis (mean GI: 0.2 - 1.0)

          -  Patients with complete natural &quot;Ramfjord-teeth&quot; or their replacement teeth

          -  Caucasian

          -  Signed Informed Consent

        Exclusion Criteria:

          -  Patients with severe systemic diseases (diabetes, hepatitis, HIV, tuberculosis,
             cancer)

          -  Patients who require endocarditis prophylaxis for dental examination and treatment

          -  Caries requiring treatment (e.g. caries with cavity) or other oral diseases (incl.
             gingival hyperplasia, diseases of the oral mucosa, periodontal screening index PSI &gt;
             2)

          -  Patients with orthodontic appliances and removable dentures

          -  Patients treated with antibiotics less than 3 months prior to the baseline examination
             at V1 and/or such a treatment planned for the duration of the trial

          -  Patients chronically treated with steroids

          -  Patients who suffer from xerostomia

          -  Patients who regularly smoke more than 10 cigarettes per day

          -  Patients who have a known hypersensitivity or allergy to the test product and its
             ingredients or to medications that have a similar chemical structure

          -  Participation of the patient in another clinical trial within the last four weeks
             before enrollment in this trial

          -  Incapability of assessing essence and possible consequences of the trial (e.g.
             alcoholism)

          -  Pregnant or breastfeeding women

          -  Women with childbearing potential except those who fulfill the following criteria:

               -  Post-menopausal (12 month of natural amenorrhoea or 6 months of amenorrhoea with
                  Serum FSH &gt; 40 U/ml)

               -  Postoperative (6 weeks after bilateral ovariectomy with or without hysterectomy)

               -  Continuous and correct application of a contraception method with a Pearl Index &lt;
                  1% (e.g. implants, depots, oral contraceptives, intrauterine device - IUD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katrin Lorenz, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Poliklinik für Parodontologie Med. Fakultät C. G. Carus der TU Dresden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Poliklinik für Parodontologie Med. Fakultät C. G. Carus der TU Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abteilung für Parodontologie in der Poliklinik für Zahnerhaltung und Parodontologie der Universität Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2013</study_first_submitted>
  <study_first_submitted_qc>May 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2014</study_first_posted>
  <last_update_submitted>May 12, 2014</last_update_submitted>
  <last_update_submitted_qc>May 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Octenidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

